UNPACKED

← Frontpage

**When Weight Loss Drugs Meet Longevity Drinks**

23h ago · 4 sources · trend

Nestlé just launched its first-ever drinks line aligned with the healthy longevity trend. Not a small side bet. The elderly nutrition market is projected to hit $43.1bn by 2032, and beverages are seen as a leading category because they allow frequent consumption and functional fortification without sacrificing taste.

Zoom out and the demand drivers get clearer. Malnutrition among the elderly carries a global average prevalence of 18.6%, with rates reaching 35.7% in Africa and 18.3% in Asia. At the same time, eating patterns are shifting fast. Around 13.3% of US consumers are already using GLP-1 medications, with adoption projected to reach 21% by 2030. These drugs are reshaping how, when and how much people eat. Think smaller portions and more frequent meals, not a mass exit from food.

Retail is moving too. Holland & Barrett has partnered with Phlo to signpost customers to GLP-1 services like Wegovy and Mounjaro. Its data shows 55% of UK adults wish they could manage their weight better, 64% are actively managing it and 33% are trying to lose weight. Roughly 1 in 10 people develop at least one new nutritional deficiency after six months on a GLP-1 drug.

Why it matters. The future of CPG is not less food. It is smarter food. Protein-rich drinks, fibre, prebiotics, muscle and mobility support. If appetites shrink and deficiencies rise, the brands that win will be the ones that pack more nutrition into every sip.

Key facts

  • Nestlé recently launched its first-ever drinks line aligned with the healthy longevity trend as the elderly nutrition market experiences particularly robust growth.
  • By 2032, the elderly nutrition market is expected to reach $43.1bn (€36.8bn).
  • Around 13.3% of US consumers are using GLP-1 medications, with adoption projected to reach around 21% by 2030.
  • GLP-1 medications are reshaping how, when and how much people eat, with smaller portions and more frequent meals rather than a mass exit from food categories.
  • Holland & Barrett has partnered with clinical weight management services provider Phlo to signpost customers to GLP-1 services such as Wegovy and Mounjaro in-store and online.
  • Holland & Barrett’s consumer data shows 55% of UK adults wish they could manage their weight better, 64% are actively managing their weight and 33% are actively trying to lose weight.
  • Research cited by Holland & Barrett indicates roughly one in 10 people develop at least one new nutritional deficiency after taking a GLP-1 drug for six months.
  • Beverages are identified as a leading category for healthy ageing because they support frequent consumption and functional fortification without compromising taste.
  • Protein-rich snacks and drinks are being positioned around muscle maintenance, satiety and mobility support as consumers age, while fibre and prebiotics are gaining traction for digestive health and metabolic wellbeing.
  • Malnutrition among the elderly has a global average prevalence of 18.6%, with regional variation including 35.7% in Africa and 18.3% in Asia.
  • $43.1bn
  • 13.3%
  • 21%
  • 55%
  • 64%
  • 33%
  • 1 in 10
  • 18.6%

Coverage